Desloratadine set for OTC switch across Europe

19 October 2020 - Deborah Wilkes

Premium

Teva’s Desloratadine ratiopharm is set to become the sixth medicine to gain non-prescription status through the European Union’s centralised authorisation procedure.

Click tags below for more information on topics:

Teva

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: